Sanofi Pasteur at the forefront of prevention...
Sanofi Pasteur is at the forefront of prevention of the meningococcal disease all over the world, developping innovative vaccines and continually improving their properties.
- MenQuadTT: new advanced meningococcal ACYW conjugate candidate vaccine is currently in Phase III.
All commercialized meningococcal vaccines are pre-qualified by the WHO.
40 years against meningitis
B-roll - Vaccine activity images
Media Contact (only for Medias)
+33 (0)1 53 77 46 46